Healthcare provider profile · identity verified

Jane Kelley

Family Practice · NEW CASTLE, PA · NPI 1063428100

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	458	116
Atorvastatin Calcium	Atorvastatin Calcium	443	110
Levothyroxine Sodium	Levothyroxine Sodium	408	91
Lisinopril	Lisinopril	326	75
Simvastatin	Simvastatin	308	69
Fluticasone Propionate	Fluticasone Propionate	282	89
Sertraline Hcl	Sertraline Hcl	192	52
Potassium Chloride	Potassium Chloride	137	35
Alendronate Sodium	Alendronate Sodium	124	33
Rosuvastatin Calcium	Rosuvastatin Calcium	121	37
Losartan Potassium	Losartan Potassium	116	31
Metformin Hcl	Metformin Hcl	109	28
Hydrochlorothiazide	Hydrochlorothiazide	101	29
Gabapentin	Gabapentin	99	19
Allopurinol	Allopurinol	97	17
Duloxetine Hcl	Duloxetine Hcl	85	13
Metoprolol Succinate	Metoprolol Succinate	84	19
Pravastatin Sodium	Pravastatin Sodium	83	18
Meloxicam	Meloxicam	76	31
Ezetimibe	Ezetimibe	72	20
Synthroid	Levothyroxine Sodium	70	19
Atenolol	Atenolol	67	17
Furosemide	Furosemide	64	24
Omeprazole	Omeprazole	64	19
Metoprolol Tartrate	Metoprolol Tartrate	58	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	15
Glimepiride	Glimepiride	51	15
Zolpidem Tartrate	Zolpidem Tartrate	48	suppressed
Citalopram Hbr	Citalopram Hydrobromide	46	13
Montelukast Sodium	Montelukast Sodium	46	15
Eliquis	Apixaban	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Methylprednisolone	Methylprednisolone	43	39
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	20
Escitalopram Oxalate	Escitalopram Oxalate	39	12
Oxybutynin Chloride Er	Oxybutynin Chloride	37	suppressed
Glipizide Er	Glipizide	31	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	26
Januvia	Sitagliptin Phosphate	28	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	27	13
Metformin Hcl Er	Metformin Hcl	26	suppressed
Ozempic	Semaglutide	25	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Linzess	Linaclotide	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Valsartan	Valsartan	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Naproxen	Naproxen	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	suppressed
Carvedilol	Carvedilol	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Azithromycin	Azithromycin	14	14
Bumetanide	Bumetanide	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	13
Fenofibrate	Fenofibrate	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Baclofen	Baclofen	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Prednisone	Prednisone	12	12
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Famotidine	Famotidine	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Primidone	Primidone	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error